Wasatch Advisors
VC Fund
Salt Lake City, United States
Wasatch Advisors is an investment management company specializing in equity funds. The company manages institutional and individual portfolios. The company was formed in 1975 by Sam Stewart and still follows his philosophy of a bottom-up research method that focuses on long-term growth and finding market inefficiencies.Wasatch Advisorsmaintains its headquarters at Salt Lake City, Utah.
- Total investments:
- 21
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Wasatch Advisors invests in
BiotechnologyHealth CareComputerSoftwareManufacturing
Stages Wasatch Advisors invests in
Series CSeries DSeries EFunding RoundSeries B
Countries Wasatch Advisors invests in
United StatesIndia
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dan Chace
|
|||
David Powers
|
|||
JB Taylor
|
|||
Jim Larkins
|
|||
John Malooly
|
|||
| See all 19 contacts → | |||
Investment Focus
Industry
- Biotechnology 6 (29%)
- Health Care 5 (24%)
- Computer 3 (14%)
- Software 3 (14%)
- Manufacturing 3 (14%)
Stage
- Series C 6 (29%)
- Series D 4 (19%)
- Series E 3 (14%)
- Funding Round 3 (14%)
- Series B 2 (10%)
Country
- United States 17 (81%)
- India 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Dan Chace
CFA
|
CFA | Total investments: 0 | Find email | |
|
David Powers
CFA
|
CFA | Total investments: 0 | Find email | |
|
JB Taylor
Team member
|
Team member | Total investments: 0 | Find email | |
|
Jim Larkins
Team member
|
Team member | Total investments: 0 | Find email | |
|
John Malooly
CFA
|
CFA | Total investments: 0 | Find email | |
| See all 19 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Frequency Therapeutics
|
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts. | $42.3M / Post-IPO Equity / Jul 17, 2020 | |
Medallia
|
Medallia helps companies win through customer and employee experience. It offers a SaaS platform that captures experience data from signal fields emitted by customers and employees. The platform utilizes AI technology to analyze structured and unstructured data from these signal fields across human, digital, and internet of things, or IoT,interactions. Using Medallia Experience Cloud, customers can reduce churn, turn detractors into promoters and buyers, and create in-the-moment cross-sell and up-sell opportunities, providing clear and potent returns on investment.The company was founded in 2001 and is headquartered in San Francisco, California. | $70M / Series F / Feb 28, 2019 | |
Quess Corp
|
Quess Corp Ltd., India’s largest business services provider established in 2007. Headquartered in Bengaluru, the company has over 1,10,000 employees, serves over 1500 customers across 8 countries in more than 8000 locations. It has presence across 5 segments namely, Global Technology Solutions Group, Industrial Asset Management Group, IntegratedFacilities Management Group, People Services & Logistics Group and Growth Businesses Group. | $26.5M / Jun 28, 2016 | |
Docusign
|
DocuSign operates a cloud-based electronic signature platform that helps small- and medium-sized businesses, enterprises, and individuals collect information, automate data workflows, and sign on various devices.The company’s platform automates manual and paper-based processes that allow users to manage various aspects of documented businesstransactions, including identity management, authentication, digital signature, forms and data collection, collaboration, and workflow automation and storage.The company also provides training and support services. Its platform serves the sales, human resources, finance, information technology, operations, legal, marketing, facilities, support, product management, and procurement departments in the financial services, healthcare, technology, higher education, insurance, real estate, life sciences, and government sectors in the United States and internationally.DocuSign was incorporated in 2003 and is based in San Francisco, California with additional offices in London, Sydney, Sao Paulo, and Dublin. | $300M / Series F / May 12, 2015 | |
DataStax
|
DataStax delivers an open, multi-cloud data stack built on Apache Cassandra™—the world’s most scalable database. The company’s marquee offering is DataStax Astra DB, the industry’s first and only open, multi-cloud serverless database. Built on a modern, microservices-based architecture, Astra DB delivers Cassandra-as-a-service with an unprecedentedcombination of pay-as-you-go data, simplified operations, and the freedom of multi-cloud and open source. With DataStax, any developer or enterprise can now deploy data at massive scale, with 100 percent uptime, for lower cost. Today, nearly 500 of the world’s most demanding enterprises and half of the Fortune 100 rely on DataStax to power modern data apps, including The Home Depot, T-Mobile, US Bank, and Intuit. | $106M / Series E / Sep 04, 2014 | |
Tethys BioScience
|
Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in thedevelopment of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California. | $25M / Series D / Nov 09, 2009 | |
Incipient
|
Incipient, engages in the development of enterprise-class storage, storage area networks (SAN) storage virtualization, and automated data migration software solutions. It offers Incipient Automated Data Migration Software for data migration projects, such as data center moves, storage array refreshes, application tiering, and storage resourcebalancing; and Incipient Network Storage Platform Software, which combines storage virtualization technology with management allowing customers to move data across their SAN environment. The company also offers data migration, automated storage provisioning, data copy services, and data protection solutions. It serves data migration, storage virtualization, storage provisioning, storage area networks management, and copy services markets. The company distributes its products through channel partners. Incipient, Inc. was founded in 2001 and is headquartered in Waltham, Massachusetts. | $15.6M / Series E / Feb 20, 2008 | |
Ocera Therapeutics
|
Ocera is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need.Ocera's HE clinical development efforts include a recently completed Phase 2b clinical trial, STOP-HE, which evaluated the safety andefficacy of intravenously-administered OCR-002 in resolving neurocognitive symptoms of acute HE in hospitalized patients with elevated ammonia. Ocera is preparing to meet with the FDA later this year to review the IV program and discuss potential development paths forward. | $35.5M / Series C / Feb 20, 2008 | |
Orqis Medical
|
ORQIS Medical Corporation operates as a medical device company. It develops and sells minimally invasive devices for improving cardiac performance through aortic flow therapy. It offers Cancion System, a heart failure treatment that uses continuous aortic flow augmentation technology to improve symptoms of heart failure and change the underlyingcourse of the disease for patients hospitalized for de-compensated heart failure. The company’s products also include Exeleras System to treat chronic heart failure patients. | $12M / Series D / Mar 27, 2007 | |
Standard BioTools
|
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation wasfounded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California. | $37M / Series E / Jan 08, 2007 | |
| See all 21 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Climate Investors
40,325 investors
Hardware Investors
40,144 investors
Consumer Investors
32,380 investors
Manufacturing Investors
24,696 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
FAQ
What does Wasatch Advisors invest in?
Wasatch Advisors invests primarily in Biotechnology, Health Care and Computer startups, most often at Series C and Series D stage. Most of the 21 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Wasatch Advisors?
Public channels for Wasatch Advisors include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Wasatch Advisors?
The team at Wasatch Advisors includes Dan Chace (CFA), David Powers (CFA) and JB Taylor (Team member), among 19 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
